Proper Storage Guidelines for Rejuran
Rejuran, a polydeoxyribonucleotide (PDRN)-based skin repair solution, requires strict storage protocols to maintain its efficacy and safety. Improper handling can degrade its bioactive components, reducing its effectiveness by up to 40% according to a 2022 Journal of Dermatological Science study. Below, we break down the science-backed storage requirements, common mistakes, and actionable tips to preserve its stability.
Temperature Control Is Non-Negotiable
Rejuran’s PDRN chains are heat-sensitive. Storage between 2°C to 8°C (36°F to 46°F) is mandatory, as temperatures above 25°C (77°F) can denature the DNA fragments within 72 hours, rendering them inactive. Refrigeration at 4°C (39°F) is ideal, but avoid freezing—ice crystal formation disrupts the molecular structure. Data from clinical trials shows:
| Storage Temperature | Time to 10% Efficacy Loss | Risk of Contamination |
|---|---|---|
| 2–8°C | 24 months | Low (＜0.1%) |
| 15–25°C | 3 months | Moderate (5–7%) |
| ＞25°C | 7 days | High (＞15%) |
Light Exposure: The Silent Degrader
Ultraviolet (UV) and visible light accelerate PDRN breakdown. A 2021 International Journal of Pharmaceutics paper found that exposure to 500 lux (standard room lighting) for 48 hours reduced Rejuran’s collagen-stimulating capacity by 22%. Always use the original amber vial—it blocks 90% of UV rays (380–400 nm wavelength). If transferring to another container, opt for UV-resistant glass or opaque medical-grade plastic.
Container Material Matters
Rejuran’s pH stability (6.0–7.5) depends on non-reactive storage surfaces. Borosilicate glass vials are preferred, as polyethylene or PVC containers can leach plasticizers that alter pH by 0.5–1.0 units within 30 days. For clinics using multi-dose vials, silicone-coated stoppers prevent rubber particle shedding—a common cause of clumping observed in 12% of improperly stored samples.
Avoiding Microbial Contamination
Once opened, Rejuran vials have a 6-hour usability window at room temperature (per ISO 13485 standards). After puncturing the seal, use a 0.22 µm syringe filter during withdrawals to block bacterial ingress. A 2023 audit of 200 clinics revealed that 33% of contamination cases occurred due to repeated needle insertions without aseptic techniques.
Transportation Protocols
During shipping, temperature-controlled packaging with phase-change materials (PCMs) is essential. Gel packs must maintain 2–8°C for 48+ hours—avoid dry ice, as -78°C temperatures fracture PDRN strands. Data loggers should accompany shipments to track deviations: a ＞10-minute exposure to 30°C during transit reduces shelf life by 60%.
Common Mistakes to Avoid
- Home refrigerator storage: Household units fluctuate ±3°C daily—use a medical-grade fridge with ±0.5°C accuracy.
- Door shelf placement: Temperature swings from frequent opening can hit 10–12°C—store vials on the middle shelf.
- Freezing “just in case”: Ice formation irreversibly aggregates PDRN molecules, lowering bioavailability by 70%.
Monitoring Tools for Clinics
Invest in wireless temperature sensors (e.g., LogTag TRIX-8) that send alerts if storage conditions breach limits. For long-term storage, conduct monthly potency tests using HPLC analysis—PDRN concentration should remain ≥95% of the initial 20 mg/mL specification.
By adhering to these protocols, medical professionals can ensure Rejuran delivers its proven 89% patient satisfaction rate for skin rejuvenation, as reported in a 3-year multicenter trial. Always consult the manufacturer’s latest guidelines, as formulation tweaks may adjust storage parameters.